Benign primary cardiac tumours in a tertiary centre: 10-year casuistic of presentation, imaging workflow and outcomes

Clicks: 2
ID: 323344
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #282 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Although benign primary cardiac tumours are rare, they carry clinically relevant embolic risk and potential haemodynamic compromise. Contemporary real-world descriptions can inform practical diagnostic pathways in cardiology. Purpose To describe baseline characteristics, clinical presentation, echocardiographic phenotype, imaging workup, treatment and outcomes of benign primary cardiac tumours in a tertiary centre over the last 10 years. Methods Single-centre retrospective 10-year registry including adults with benign primary cardiac tumours (N=28). All patients underwent surgical resection. Variables included demographics and comorbidities, mode of detection, symptoms and "hard events" (embolic events, arrhythmias), echocardiographic features (location, maximal diameter, mobility, pedicle, obstruction, pericardial effusion), additional imaging (TEE/CMR/CT), and follow-up outcomes (recurrence, mortality). Results are reported as median (IQR) or n (%). Results Median age was 63.0 years (45.0–70.0), and 10/28 (35.7%) were male. Hypertension was present in 12/28 (42.9%), diabetes in 4/28 (14.3%), coronary artery disease in 5/28 (17.9%), and prior atrial fibrillation in 1/28 (3.6%). Most patients were NYHA I–II (27/28). Detection occurred mainly in outpatient pathways (15/28), emergency setting (6/28) or as incidental findings (6/28); one case had missing categorisation. Patients were asymptomatic in 9/28 (32.1%), embolic events occurred in 7/28 (25.0%), and arrhythmias in 4/28 (14.3%). Histology comprised myxoma (20/28) and papillary fibroelastoma (8/28). Tumours were most frequently located in the left atrium (18/28), followed by valvular location (5/28). Median maximal diameter was 24.0 mm (15.0–41.0). Obstruction was present in 5/28 (17.9%). No pericardial effusions were recorded. TEE was performed in 15/28 (53.6%), CMR in 2/28 (7.1%), and CT in 3/28 (10.7%). Complete resection (R0) was achieved in all cases, with no documented recurrences. Two deaths occurred during follow-up (7.1%). Median follow-up (final diagnosis to last contact) was 10.3 months (5.2–28.2). Conclusions Over the last decade, benign primary cardiac tumours in our tertiary centre were dominated by myxoma and papillary fibroelastoma, with a substantial burden of embolic presentation. TTE and TEE were the principal diagnostic tools, and outcomes were favourable with no documented recurrence. Despite benign histology, the observed embolic rate underscores the need for streamlined diagnostic-to-treatment pathways to mitigate preventable complications.
Reference Key
openalex_W7172282217 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors T Prata Branco, E Andrade, L Lorenzo Alves, B Couto Viana, J Goncalves, B Cruz, E Oliveira, M Rocha, H Santos Moreira, P Mangas Palma, M Paiva, R A Rodrigues
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.021
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.